A point in common among the firms in our selection is that their share price has fallen sharply in 2022, sometimes contrary to economic logic. But they also share a solid business model and a proven track record.
The US Federal Reserve has shaken up the markets by making several interest rate hikes since the start of the year to combat inflation. The dollar is soaring, while the euro and sterling have declined. The threat of recession looms.
The war in Ukraine will have lasting effects on the global economy – how extensive those effects will be is currently unknown. While markets have returned to their pre-crisis levels, the shadow of stagflation weighs heavily on Europe.
Aswath Damodaran, professor of finance at New York University Stern School of Business, breaks down the major trends that will affect markets in 2022 and investment opportunities. Find out more in this interview.
Now that concerts are back on and streaming continues to attract more users, 2022 is shaping up to be a record year for the music industry. That’s a tremendous turnaround for a sector that was languishing just 10 years ago.
With an international career spanning 40 years, the Swiss singer has experienced the music industry revolution from the inside. He therefore understands all its inner workings. In this interview, he speaks openly and honestly with Swissquote Magazine.
In these days when digital technology is taking over the world, Europe can no longer depend on turnkey services provided by the United States. And its companies are ready to step up to the challenge. Here is our selection.
Alexandre Pauchard, the new CEO of CSEM (Swiss Centre for Electronics and Microengineering), shares his perspective on the Old Continent’s weaknesses in digital technology, while being optimistic about the future.
Due to a strong increase in global demand combined with limited resources, the water market has a bright future ahead of it. Currently worth more than $800 billion, the sector is expected to grow by at least 6% per year.
The water market is in the hands of various companies active in very different industries, including building infrastructure, micro-pollutant detection and wastewater treatment. We take a closer look at them.
Offering direct-to-consumer genetic testing, gene therapies, and even incredible IT storage solutions, the DNA business continues to grow. A myriad of companies are taking advantage of it. Here’s an overview.
"Messenger RNA could be used to treat any illness"
As Switzerland approves two COVID‑19 vaccines that use messenger RNA, Steve Pascolo – a researcher at University Hospital Zurich, an industry pioneer and a busy entrepreneur – explains the potential for these new types of therapeutic solutions. Find out more in this interview.
The five commandments of a good dividend strategy
Over the last 10 years or so, the shares of companies offering high dividend yields have underperformed the market. But by building a selective value portfolio, investors can still come out ahead. We take a closer look.